Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Medium-wave-sensitive opsin 3 (OPN1MW3) is a photopigment protein and member of the G protein-coupled receptor family, specifically expressed in cone photoreceptor cells of the retina that are responsible for detecting light in the middle wavelengths (green/yellow spectrum)[1][2][3]. It is one of several paralogs of the OPN1MW gene cluster on chromosome X and encodes an opsin protein that binds a retinal chromophore to enable color discrimination and light perception[1][5]. Mutations or rearrangements involving OPN1MW/OPN1MW3 cause X-linked red-green color vision deficiencies (deuteranopia, deuteranomaly), cone dystrophies, and are implicated in age-related macular degeneration[1][2][3]. OPN1MW3 is not considered a therapeutic drug target in current clinical use, and there are no marketed drugs designed to modulate its function. Notes on accuracy and conventions: - OPN1MW3 is not a commonly recognized or distinct clinical/therapeutic target; the canonical gene for human green opsin is OPN1MW. - OPN1MW3 is sometimes listed as a paralog or pseudogene, and most clinical/disease literature refers to OPN1MW, not OPN1MW3[2][3][5]. - The listing of OPN1MW3 is likely due to complex genomic arrangements and multiple gene copies; consequently, the “is_incorrect” flag is set to true because OPN1MW3 is not a standard, distinct therapeutic target and most validated functional disease associations reference the OPN1MW gene[1][2][3].
N/A (no known drugs targeting OPN1MW3 directly; general opsins interact with cis-retinal as chromophore for vision)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Medium-wave-sensitive opsin 3 (OPN1MW3).